# CareOS Module 6 completion report

**Module:** M6 Clinical assessment (`COS-01` through `COS-27`)  
**Repository construction status:** complete and module-focused verification passed  
**Verification date:** 28 September 2026  
**Consolidated QA:** deferred under the project's continuous execution direction  
**Production status:** not approved; protected COS source assets, accountable clinical policy and target-environment activation remain separate

## Completed scope

- V90 releases nine migration-owned assessment permissions/operations. V91 creates the twelve required tenant-owned relations with composite tenant integrity, UUIDv7 identifiers, forced RLS and append-only evidence controls. V92 adds payload-minimized audit/outbox contracts plus direct lifecycle, provenance, review, signing and amendment guards.
- `COS-01` through `COS-27` now use checked tenant-authorized server projections and governed actions while preserving the repository's exact existing route names and order. The missing protected source package is stated visibly and is not represented as source-verified visual acceptance.
- Starting an assessment binds one verified patient, active encounter and eligible responsible clinician, then creates exactly 27 ordered sections. Responses append immutable versions; no prior clinical content is overwritten.
- Every response, narrative and measurement retains attribution and source/method context. Measurements require purpose, baseline state, unit/scale, cadence, owner and action threshold; a composite cure score is prohibited in both application and database boundaries.
- Red flags retain visible raised, acknowledged and resolved states. Review, signing and completion fail closed while unresolved safety evidence remains.
- Review binds explicit completeness, source and uncertainty confirmations to the exact assessment revision. Signing requires recent authentication, MFA and the eligible responsible clinician. Amendments append to the signed evidence rather than rewriting it.
- The browser shows verified patient/responsible-clinician context, ordered 27-step progress and a visible 700 ms debounced autosave. Each save uses the latest strong ETag, caller-owned idempotency and an explicit conflict state; silent last-write-wins behavior is not permitted.
- `COS-24` retains its ordered position but exposes no AI synthesis mutation before the separately governed Module 8 boundary exists.

## Repository evidence

| Gate | Result | Evidence |
| --- | --- | --- |
| Backend compilation and assessment verification | PASS | Java 25/Maven 3.9.11 compiles 415 production and 42 test sources. The focused catalogue/registry/lifecycle run validates and applies V1-V92 to disposable PostgreSQL 18 and passes 5/5 tests. |
| Assessment lifecycle and evidence | PASS | The integration path starts 27 sections, appends two response versions, records a purpose-bound measurement, proves red-flag review blocking, acknowledges/resolves the flag, reviews, MFA-signs, amends and completes the assessment, verifies minimized audit/outbox evidence and rejects direct response-version rewriting. |
| API and generated client | PASS | OpenAPI 3.1 version 0.45.0 verifies exactly 118 operations; generated TypeScript has no drift and all 22 positive/negative API-contract cases pass. |
| Frontend static/unit/build | PASS | Formatting, strict typecheck, lint, the 43-source/7-feature/120-import boundary plus four negative fixtures, all 102 unit tests and the production build pass. |
| Module 6 browser/accessibility/responsive | PASS | Every COS route, the governed `COS-09` debounced autosave flow and `COS-27` closeout boundary pass in 15 Playwright cases across exact 1440, 1024, 768, 390 and 320 projects, including Axe and document-overflow checks. |
| Public catalogue | PASS | The public registry remains 122 screens: M1 23, M2 29, M3 16, M4 15, M5 12 and COS 27. |

## Deferred QA and activation

The project-wide cross-module regression, supply-chain/image/deployment reruns and target-environment acceptance remain deferred until consolidated QA. This report does not approve production clinical content or use.

Production activation still requires the original protected COS source package and exact copy/components/navigation review; approved instruments and versions; accountable local red-flag thresholds/escalation policy; terminology and interpretation policy; legal attestation wording; practitioner/service catalogues; target providers/workers; monitoring; backup/restore; deployment evidence; and operational sign-off. The current structural runtime explicitly reports the unavailable source-package state and does not fabricate those inputs.

## Next dependency

Module 7 Documents and Results may consume the governed patient, encounter and assessment context plus the existing quarantine/scan/promotion/access/retention platform ports. It must keep external laboratory, imaging, document-provider and local result-review policies fail closed until approved target inputs exist.
